We also found that variants in TRIB1, TM6SF2 and APOE had stronger effects on NAFLD compared with cirrhosis, indicating that they may primarily exert their effect on cirrhosis via fatty liver disease. Here, TRIB1 is linked to metabolic dysfunction-associated steatotic liver disease.